Brought to you by 
Moderna closes $450mm third round
03 Feb 2015
Executive Summary
Messenger RNA firm Moderna Therapeutics LLC closed the largest biotech venture funding round to date, bringing in $450mm through its third financing from a group of 43 investors that included new buyers Viking Global Investors, Invus, RA Capital, and Wellington Management, along with returning backers AstraZeneca, Alexion Pharmaceuticals, and 37 others.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Antisense, Oligonucleotides
- Large Molecule
-
Drug Discovery Tools
- Genomics-Proteomics
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com